Vaxxinity Investor Relations Material
Latest events
Q4 2023
27 Mar, 2024
Corporate Presentation
12 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vaxxinity Inc
Access all reports
Vaxxinity Inc. is a biotechnology company focused on developing immunotherapies for chronic diseases and infectious conditions. The company specializes in vaccine-based treatments designed to harness the immune system for conditions such as neurodegenerative disorders, cardiovascular diseases, and viral infections. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
)
)
)